Table 2.
First two weeks | Last two weeks | P-value | ||
---|---|---|---|---|
Average daily steps | 4,952.6 ± 3,052.7 | 6,119.6 ± 3,776.2 | <0.001 | |
Average heart rate | 73.1 ± 11.1 | 71.4 ± 10.6 | ns | |
Beginning of follow-up | End of follow-up | P-value | ||
Left ventricular ejection fraction (%) | 25.8 ± 6.6 | 37.5 ± 10.7 | <0.001 | |
Δ-Steps | 1,167.1 ± 2,455.9 | |||
Δ-LVEF (%) | 11.6 ± 10.6 | |||
Wearing Time (hours) | 22.8 ± 2.1 | |||
Days carried | 77.3 ± 44.6 |
Δ-Steps, Improvement of physical activity measured in daily steps; Δ-LVEF, Improvement of left ventricular ejection fraction.